New data provide a boost for shorter drug-resistant TB regimens – University of Minnesota Twin Cities November 16, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma | NEJM – nejm.org February 10, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma | NEJM – nejm.org February 10, 2023
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis September 1, 2022August 31, 2022